XCLW36426 急性缺血性脑卒中的发病机制及治疗进展 (字数:6367)目录1.AIS 的发病机制42.AIS 的治疗42.1 基础治疗42.1.1 保持呼吸道通畅和控制血压42.1.2血糖控制52.1.3高压氧治疗52.1.4并发症的治疗52.1.152.2溶栓治疗52.2.1动脉内溶栓62.2.3动、静脉溶栓联合应用62.3抗凝和抗血小板治疗62.3.1抗凝治疗62.3.2抗血小板治..
XCLW36426 急性缺血性脑卒中的发病机制及治疗进展 (字数:6367) 目录 1.AIS 的发病机制 4 2.AIS 的治疗 4 2.1 基础治疗 4 2.1.1 保持呼吸道通畅和控制血压 4 2.1.2血糖控制 5 2.1.3高压氧治疗 5 2.1.4并发症的治疗 5 2.1.1 5 2.2溶栓治疗 5 2.2.1动脉内溶栓 6 2.2.3动、静脉溶栓联合应用 6 2.3 抗凝和抗血小板治疗 6 2.3.1抗凝治疗 6 2.3.2抗血小板治疗 6 2.4神经细胞保护治疗 7 2.4.1 亚低温治疗 7 2.4.2自由基清除剂的应用 7 2.4.3钙通道阻滞剂 7 3.小结 7 参考文献 8 急性缺血性脑卒中的发病机制及治疗进展 摘要:脑卒中是临床常见急症之一,脑卒中已经成为影响国人健康的重要疾病,世界卫生组织调查结果显示,中国脑卒中发病率排名世界第一。在我国参与的世界卫生组织的脑卒中研究数据显示,脑血管疾病的发生率在明显上升,几乎以每年增长9% 的速率上升。我国第三次国民死因调查结果表明,脑卒中已经上升为中国第1位死因。近二十年监测结果显示,我国脑卒中年死亡人数逾200万,年增长速率达 8.7% 。脑卒中除了高致死率外,还具有高致残率和高复发率的特点,严重威胁国民生命和健康生活质量。所以进一步加大防治的研究力度,降低脑卒中的发病率和病死率,已成为当前一项刻不容缓的重要任务。 Abstract: stroke is one of the common clinical emergencies, stroke has become an important disease affecting the health of people, the WHO survey results show that the incidence of stroke in China ranked first in the world. In our country, the incidence of cerebrovascular disease increased significantly, and the rate of cerebral vascular disease increased significantly, with the incidence of cerebrovascular disease increased significantly by 9%. The third National Death survey results show that stroke has been the first leading cause of death in China. Nearly twenty years of monitoring results show that the death toll of stroke in China more than 2 million, the annual growth rate of 8.7%. In addition to high death rate, stroke patients also have the characteristics of high disability rate and high recurrence rate, which is a serious threat to the quality of life and health of the people. Therefore, to further strengthen the research efforts to reduce the incidence and mortality of stroke, has become an urgent important task. 关键词: 急性缺血性脑卒 AIS 机制 治疗
|
| |
上一篇:抗肿瘤药物靶向给药新剂的型研究.. | 下一篇:微透析技术在靶向药物研究中的应用 |
点击查看关于 急性 缺血性 卒中 发病机制 治疗 进展 的相关范文题目 | 【返回顶部】 |